RAB11FIP5 expression and altered natural killer cell function are associated with induction of HIV broadly neutralizing antibody responses

RAB11FIP5 expression and altered natural killer cell function are associated with induction of HIV broadly neutralizing antibody responses

HIV-1 broadly neutralizing antibodies (bnAbs) are difficult to induce with vaccines but are generated in ∼50% of HIV-1-infected individuals. Understanding the molecular mechanisms of host control of bnAb induction is critical to vaccine design. Here, we performed a transcriptome analysis of blood mo...

Bibliografske podrobnosti
Main Authors:	Bradley, T, Peppa, D, Pedroza-Pacheco, I, Borrow, P, al., E
Format:	Journal article
Izdano:	Cell Press 2018

Podobne knjige/članki

RAB11FIP5-deficient mice exhibit cytokine-related transcriptomic signatures
od: Li, D, et al.
Izdano: (2020)

Acquisition of Rab11 and Rab11-Fip2-A novel strategy for Chlamydia pneumoniae early survival.
od: Katja Mölleken, et al.
Izdano: (2017-08-01)

Adaptive reconfiguration of natural killer cells in HIV-1 infection
od: Peppa, D, et al.
Izdano: (2018)

Rab11-FIP1C and Rab14 direct plasma membrane sorting and particle incorporation of the HIV-1 envelope glycoprotein complex.
od: Mingli Qi, et al.
Izdano: (2013-01-01)

Rabs, Rips, FIPs, and Endocytic Membrane Traffic
od: Rytis Prekeris
Izdano: (2003-01-01)

Viral Vectors for the Induction of Broadly Neutralizing Antibodies against HIV
od: Sarah Wilmschen, et al.
Izdano: (2019-09-01)

Correction: The Rab11 Effector Protein FIP1 Regulates Adiponectin Trafficking and Secretion
Izdano: (2014-01-01)

Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies
od: Borrow, P, et al.
Izdano: (2017)

Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies
od: Garnett Kelsoe, et al.
Izdano: (2013-12-01)

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
od: Haynes, BF, et al.
Izdano: (2022)

Immune perturbations in HIV-1–infected individuals who make broadly neutralizing antibodies
od: Moody, M, et al.
Izdano: (2016)

P19-11. Generation of virus-like particles expressing different HIV-1 glycoproteins for induction of broadly neutralizing antibodies
od: Buonaguro L, et al.
Izdano: (2009-10-01)

The potential of broadly neutralizing antibodies for HIV prevention
od: Huub C. Gelderblom, et al.
Izdano: (2024-05-01)

The expanding array of HIV broadly neutralizing antibodies
od: Laura E. McCoy
Izdano: (2018-10-01)

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
od: Elise Landais, et al.
Izdano: (2018-09-01)

B cell engineering in vivo: Accelerating induction of broadly neutralizing antibodies against HIV-1 infection
od: Caijun Sun, et al.
Izdano: (2023-01-01)

Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities
od: Yubin Liu, et al.
Izdano: (2020-01-01)

HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
od: Jérémy Dufloo, et al.
Izdano: (2018-07-01)

Elimination of HIV-1-infected cells by broadly neutralizing antibodies
od: Timothée Bruel, et al.
Izdano: (2016-03-01)

Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies.
od: Laura E McCoy, et al.
Izdano: (2015-08-01)

Neutralizing the threat: harnessing broadly neutralizing antibodies against HIV-1 for treatment and prevention
od: Juan C Becerra, et al.
Izdano: (2024-07-01)

Predicting neutralization susceptibility to combination HIV-1 monoclonal broadly neutralizing antibody regimens.
od: Brian D Williamson, et al.
Izdano: (2024-01-01)

Epitope mapping of broadly neutralizing HIV-2 human monoclonal antibodies.
od: Kong, R, et al.
Izdano: (2012)

Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodies
od: Rory Henderson, et al.
Izdano: (2024-11-01)

Exploration of broadly neutralizing antibody fragments produced in bacteria for the control of HIV
od: Sarah B. Lloyd, et al.
Izdano: (2017-11-01)

Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention.
od: Bryan T Mayer, et al.
Izdano: (2022-04-01)

Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity
od: Julie Prigent, et al.
Izdano: (2018-05-01)

Computational Prediction of Broadly Neutralizing HIV-1 Antibody Epitopes from Neutralization Activity Data
od: Ferguson, Andrew L., et al.
Izdano: (2014)

The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies
od: Sok, Devin, et al.
Izdano: (2014)

Computational prediction of broadly neutralizing HIV-1 antibody epitopes from neutralization activity data.
od: Andrew L Ferguson, et al.
Izdano: (2013-01-01)

Nanodepots Encapsulating a Latency Reversing Agent and Broadly Neutralizing Antibody Enhance Natural Killer Cell Cytotoxicity Against an in vitro Model of Latent HIV
od: Ghofrani J, et al.
Izdano: (2023-07-01)

Immune checkpoint modulation enhances HIV-1 antibody induction
od: Bradley, T, et al.
Izdano: (2020)

Potent broadly neutralizing antibodies mediate efficient antibody-dependent phagocytosis of HIV-infected cells.
od: Brian J Snow, et al.
Izdano: (2024-10-01)

A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
od: Pejchal, R, et al.
Izdano: (2011)

Phage display as a tool for identifying HIV-1 broadly neutralizing antibodies
od: A. N. Chikaev, et al.
Izdano: (2021-09-01)

Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
od: Jianliang Xu, et al.
Izdano: (2024-07-01)

The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and Prevention
od: Jannifer Jasmin Thavarajah, et al.
Izdano: (2024-06-01)

To prescreen or not to prescreen for broadly neutralizing antibody sensitivity in HIV cure-related trials
od: Hursch Patel, et al.
Izdano: (2023-09-01)

Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV-1
od: Colin LaMont, et al.
Izdano: (2022-07-01)

Multiscale affinity maturation simulations to elicit broadly neutralizing antibodies against HIV.
od: Simone Conti, et al.
Izdano: (2022-04-01)